Search research articles
Contact Us
Filters
Showing results (171-180 of 213) with videos related to
Page
of 22
Sort By:
Journal of the American Academy of Dermatology
|
June 21, 2021
Late-onset adverse events of anti-PD1 therapy in melanoma patients: An observational study from MELBASE, a nationwide prospective cohort
Clémentine Carlet, Stéphane Dalle, Marie-Thérèse Leccia, et al.
Frontiers in Oncology
|
November 8, 2023
Differential gradients of immunotherapy vs targeted therapy efficacy according to the sun-exposure pattern of the site of occurrence of primary melanoma: a multicenter prospective cohort study (MelBase)
David Russo, Stéphane Dalle, Olivier Dereure, et al.
European Journal of Dermatology : EJD
|
November 18, 2015
Defining and recognising locally advanced basal cell carcinoma
Jean Michel Amici, Maxime Battistella, Marie Beylot-Barry, et al.
The New England Journal of Medicine
|
August 10, 2007
A single cycle of rituximab for the treatment of severe pemphigus
Pascal Joly, Hugo Mouquet, Jean-Claude Roujeau, et al.
Cancers
|
July 2, 2021
Tolerance and Effectiveness of Targeted Therapies in Aged Patients with Metastatic Melanoma
Ondine Becquart, Bastien Oriano, Stéphane Dalle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 2019
A Th1/IFNγ Gene Signature Is Prognostic in the Adjuvant Setting of Resectable High-Risk Melanoma but Not in Non-Small Cell Lung Cancer
Benjamin Dizier, Andrea Callegaro, Muriel Debois, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 8, 2017
Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients
Kilian Wistuba-Hamprecht, Alexander Martens, Florian Heubach, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 12, 2016
Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab
Kilian Wistuba-Hamprecht, Alexander Martens, Karin Haehnel, et al.
Journal for Immunotherapy of Cancer
|
November 14, 2020
PD-1 and TIGIT coexpression identifies a circulating CD8 T cell subset predictive of response to anti-PD-1 therapy
Sylvain Simon, Valentin Voillet, Virginie Vignard, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 26, 2019
Impact of radiotherapy administered simultaneously with systemic treatment in patients with melanoma brain metastases within MelBase, a French multicentric prospective cohort
Pauline Tétu, Clara Allayous, Bastien Oriano, et al.
Page
of 22
Search research articles
Search
Showing results (171-180 of 213) with videos related to
Sort By:
Page
of 22
Journal of the American Academy of Dermatology
|
June 21, 2021
Late-onset adverse events of anti-PD1 therapy in melanoma patients: An observational study from MELBASE, a nationwide prospective cohort
Clémentine Carlet, Stéphane Dalle, Marie-Thérèse Leccia, et al.
Frontiers in Oncology
|
November 8, 2023
Differential gradients of immunotherapy vs targeted therapy efficacy according to the sun-exposure pattern of the site of occurrence of primary melanoma: a multicenter prospective cohort study (MelBase)
David Russo, Stéphane Dalle, Olivier Dereure, et al.
European Journal of Dermatology : EJD
|
November 18, 2015
Defining and recognising locally advanced basal cell carcinoma
Jean Michel Amici, Maxime Battistella, Marie Beylot-Barry, et al.
The New England Journal of Medicine
|
August 10, 2007
A single cycle of rituximab for the treatment of severe pemphigus
Pascal Joly, Hugo Mouquet, Jean-Claude Roujeau, et al.
Cancers
|
July 2, 2021
Tolerance and Effectiveness of Targeted Therapies in Aged Patients with Metastatic Melanoma
Ondine Becquart, Bastien Oriano, Stéphane Dalle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 2019
A Th1/IFNγ Gene Signature Is Prognostic in the Adjuvant Setting of Resectable High-Risk Melanoma but Not in Non-Small Cell Lung Cancer
Benjamin Dizier, Andrea Callegaro, Muriel Debois, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 8, 2017
Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients
Kilian Wistuba-Hamprecht, Alexander Martens, Florian Heubach, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 12, 2016
Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab
Kilian Wistuba-Hamprecht, Alexander Martens, Karin Haehnel, et al.
Journal for Immunotherapy of Cancer
|
November 14, 2020
PD-1 and TIGIT coexpression identifies a circulating CD8 T cell subset predictive of response to anti-PD-1 therapy
Sylvain Simon, Valentin Voillet, Virginie Vignard, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 26, 2019
Impact of radiotherapy administered simultaneously with systemic treatment in patients with melanoma brain metastases within MelBase, a French multicentric prospective cohort
Pauline Tétu, Clara Allayous, Bastien Oriano, et al.
Page
of 22